Guggenheim Sticks to Their Buy Rating for GRAIL Inc (GRAL)
at www.tipranks.com (Tue, 10-Nov 7:36 AM)
GRAIL: Buy Rating Maintained with $150 Price Target Unchanged Amid Long-Term Growth Potential
at www.tipranks.com (Thu, 5-Nov 5:46 PM)
Piper Sandler Remains a Hold on GRAIL Inc (GRAL)
at www.tipranks.com (Thu, 5-Nov 9:28 AM)
Analysts Are Bullish on Top NA Stocks: Circle Internet Group, Inc. Class A (CRCL), GRAIL Inc (GRAL)
at www.tipranks.com (Thu, 5-Nov 9:02 AM)
GRAIL Inc (GRAL) Receives a Hold from Goldman Sachs
at www.tipranks.com (Thu, 5-Nov 7:39 AM)
RBC Capital Remains a Hold on GRAIL Inc (GRAL)
at www.tipranks.com (Thu, 5-Nov 7:38 AM)
GRAIL spotlights Galleri’s “more than 200 cancers” data ahead of two major October conferences
Market Chameleon (Tue, 6-Oct 7:07 AM)
GRAL jumps as FDA panel backs Galleri, with a 7–2 benefit-risk vote and unanimous safety support
Market Chameleon (Thu, 24-Sep 11:03 AM)
FDA panel backs GRAIL’s Galleri, with a 7–2 vote that benefits outweigh risks
Market Chameleon (Thu, 24-Sep 7:30 AM)
